Key result
Complex mitral anatomy and severe renal failure predict 1-year mortality after M-TEER for primary MR.
Why the study?
M-TEER is established for high-risk primary mitral regurgitation, but data on how anatomical complexity impacts prognosis remain scarce and conflicting.
Does mitral valve anatomical complexity predict 1-year all-cause mortality in symptomatic patients with severe primary mitral regurgitation undergoing M-TEER?
Cohort
Yes
Does mitral valve anatomical complexity predict 1-year all-cause mortality in symptomatic patients with severe primary mitral regurgitation undergoing M-TEER?
p-value: p== 0.042
Complex mitral valve anatomy and severe renal failure predict higher 1-year all-cause mortality in patients undergoing M-TEER for primary mitral regurgitation.
Background: Mitral transcatheter edge-to-edge repair (M-TEER) is an established option for high-risk primary mitral regurgitation (PMR) patients, but data on the impact of anatomical complexity on prognosis are scarce and conflicting. Objectives: The aims of this study were to characterize patients with severe PMR undergoing M-TEER, assess mid-term prognosis after M-TEER, and identify prognostic factors based on PMR mechanism. Methods: Data from symptomatic PMR patients with severe PMR treated with M-TEER between July 2013 and October 2023 at two Swiss centers were collected retrospectively until 2017 and prospectively thereafter. Patients were categorized by lesion type: A2-P2 prolapse/flail vs. non-A2-P2 prolapse/flail. A subset was classified by mitral valve (MV) anatomical complexity (defined by the presence of ≥1 of the following: ≥moderate calcifications, Barlow's disease, multiple prolapses, or commissural prolapses). Cox regression identified predictors of 1-year all-cause mortality. Results: = 0.042). Multivariate analysis identified complex MV anatomy and severe renal failure as predictors of 1-year all-cause mortality. Conclusions: MV anatomical characteristics have a significant influence on symptomatic improvement and all-cause mortality at 1 year and should be carefully considered during the selection of PMR patients for M-TEER.
No takes yet. Share an insight, caveat, or question.
Samim et al. (2025) conducted a cohort in severe primary mitral regurgitation (PMR). Mitral transcatheter edge-to-edge repair (M-TEER) vs. A2-P2 prolapse/flail vs. non-A2-P2 prolapse/flail was evaluated on 1-year all-cause mortality (p== 0.042). Complex mitral valve anatomy and severe renal failure were identified as significant predictors of 1-year all-cause mortality following M-TEER for primary mitral regurgitation (P=0.042).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: